BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3266098)

  • 21. The classical complement pathway: mechanism of activation of the first component by antigen-antibody complexes.
    Loos M
    Prog Allergy; 1982; 30():135-92. PubMed ID: 7041131
    [No Abstract]   [Full Text] [Related]  

  • 22. The ontogenetic development of the follicular dendritic cell. An ultrastructural study by means of intravenously injected horseradish peroxidase (HRP)-anti-HRP complexes as marker.
    Dijkstra CD; Kamperdijk EW; Döpp EA
    Cell Tissue Res; 1984; 236(1):203-6. PubMed ID: 6370452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of TNP-conjugated polyacrylamide beads in a C1q binding inhibition test for circulating immune complexes.
    Schmidt R; Walther S; Sodomann CP
    Immunobiology; 1982; 162(2):153-64. PubMed ID: 6981581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
    Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
    Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C1q component of complement binds to fibrinogen and fibrin.
    Entwistle RA; Furcht LT
    Biochemistry; 1988 Jan; 27(1):507-12. PubMed ID: 3258162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C1q induces chemotaxis and K+ conductance activation coupled to increased cytosolic Ca2+ in mouse fibroblasts.
    Oiki S; Okada Y
    J Immunol; 1988 Nov; 141(9):3177-85. PubMed ID: 3262684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of immune complex lattice on the C1q solid phase assay as determined with covalently cross-linked immune complexes.
    Wener MH; Mannik M
    Clin Exp Immunol; 1983 Jun; 52(3):543-50. PubMed ID: 6603296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating immune complexes in breast cancer patients.
    Croce MV; Pasqualini RS; Segal-Eiras A
    Medicina (B Aires); 1987; 47(4):371-6. PubMed ID: 3502571
    [No Abstract]   [Full Text] [Related]  

  • 29. Dendritic cells in the arterial wall express C1q: potential significance in atherogenesis.
    Cao W; Bobryshev YV; Lord RS; Oakley RE; Lee SH; Lu J
    Cardiovasc Res; 2003 Oct; 60(1):175-86. PubMed ID: 14522421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of horseradish peroxidase (HRP)-anti-HRP complexes in cryostat sections: influence of endotoxin on trapping of immune complexes in the spleen of the rat.
    Dijkstra CD; te Velde AA; Van Rooijen N
    Cell Tissue Res; 1983; 232(1):1-7. PubMed ID: 6349815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C1q-binding substances in peripheral lymph in bronchial carcinoma.
    Heier HE; Sokolowski JA; Solheim OP
    Lymphology; 1978 Dec; 11(4):170-3. PubMed ID: 739789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C1q binding and C1 activation by various isolated cellular membranes.
    Storrs SB; Kolb WP; Olson MS
    J Immunol; 1983 Jul; 131(1):416-22. PubMed ID: 6602834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 125I-C1q binding activity of soluble antigen-antibody complexes formed in vitro.
    Soltis RD; Hasz DE
    J Clin Lab Immunol; 1982 Nov; 9(2):121-31. PubMed ID: 6984078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C1q inhibits the expression of B lymphoblastoid cell line interleukin 1 (IL 1).
    Habicht GS; Beck G; Ghebrehiwet B
    J Immunol; 1987 Apr; 138(8):2593-7. PubMed ID: 3494080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transport of immune complexes from the subcapsular sinus into the lymph node follicles of the rat.
    Kamperdijk EW; Dijkstra CD; Döpp EA
    Immunobiology; 1987 Aug; 174(4-5):395-405. PubMed ID: 3679278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A monoclonal antibody to C1q which appears to interact with C1r2C1s2-binding site.
    Hsiung L; Dodds AW; Mason DW; Reid KB
    FEBS Lett; 1988 Feb; 229(1):21-4. PubMed ID: 2831088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma.
    Carsons SE; Schwartzman S; Diamond HS; Berkowitz E
    Clin Exp Immunol; 1988 Apr; 72(1):37-42. PubMed ID: 3135129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the role of tyrosine residues in human IgG and rabbit IgG in binding of complement subcomponent C1q.
    McCall MN; Easterbrook-Smith SB
    Biochem J; 1989 Feb; 257(3):845-51. PubMed ID: 2784672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.